semaglutide news november 28 2025 The FDA sent a warning letter to the maker of Ozempic and Wegovy over unreported potential GLP-1 side effects. Here's what to know CMS Moved to Expand Obesity

doi: 10.1056/NEJMe1202168 Sizar O, Khare S, Jamil RT, Talati R

Sodium-Glucose Co-Transporter-2 Inhibitors and All-Cause Mortality: A Meta-Analysis of Randomized Controlled Trials

What if semaglutide doesn't work for me after 4 weeks

If you experience any of these symptoms, it is essential to seek medical attention immediately

This review highlights tirzepatide, a novel dual agonist of GLP-1 and GIP receptors, which has demonstrated significant improvements in glycemic control, weight loss, and potential cardiovascular and renal benefits, marking it as a promising advancement in T2D treatment

Topiramate can cause dizziness, tiredness, and memory problems